Advertisement
Join us for a breakfast meeting at AAO 2025 to learn about Spiral's latest advancements, including clinical plans for SPT-2101 for Meniere'sAbout this Event
Our lead program, SPT-2101, is a novel dexamethasone formulation for Meniere’s Disease and is on track to enter pivotal U.S. trials in 2026.
At this meeting, we will:
- Share the latest development progress for SPT-2101.
- Gather your expert feedback on clinical study design and drug delivery procedure.
- Explore opportunities for you to participate as a principal investigator and collaborator in our upcoming multi-center clinical trial.
Arrive early (6:30 AM) for a special pre-meeting session to test-drive our new microendoscope — featuring the world’s smallest camera. Hands-on with PHACON models, this is your chance to shape the usability and design with direct feedback.
Advertisement
Event Venue & Nearby Stays
JW Marriott Indianapolis, 10 South West Street, Indianapolis, United States
Tickets
USD 0.00
